Tectonic Therapeutic Past Earnings Performance
Past criteria checks 0/6
Tectonic Therapeutic's earnings have been declining at an average annual rate of -19.5%, while the Biotechs industry saw earnings growing at 19.1% annually.
Key information
-19.5%
Earnings growth rate
-14.5%
EPS growth rate
Biotechs Industry Growth | 17.0% |
Revenue growth rate | n/a |
Return on equity | n/a |
Net Margin | n/a |
Last Earnings Update | 31 Mar 2024 |
Recent past performance updates
No updates
Revenue & Expenses Breakdown
How Tectonic Therapeutic makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
31 Mar 24 | 0 | -44 | 8 | 35 |
31 Dec 23 | 0 | -43 | 8 | 37 |
30 Sep 23 | 0 | -45 | 8 | 38 |
31 Dec 22 | 0 | -32 | 7 | 26 |
Quality Earnings: TECX is currently unprofitable.
Growing Profit Margin: TECX is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: Insufficient data to determine if TECX's year-on-year earnings growth rate was positive over the past 5 years.
Accelerating Growth: Unable to compare TECX's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: TECX is unprofitable, making it difficult to compare its past year earnings growth to the Biotechs industry (0.5%).
Return on Equity
High ROE: TECX's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.